glp-1 or metformin GLP-1s lower death risk in adults with type 2 diabetes, cancer GLP-1 RA initiation versus metformin

Pelletier JP, Fernandes JC, Brunet J, et al

AOD 9604 regulatory status AOD 9604 is not FDA-approved for any medical indication

11 Clinical Pearls Patients should be counselled on the potential effects of their systemic medications on their ocular health and vision GLP-1 receptor agonists may serve an adjunct role in helping patients with IIH achieve optimal weight and guard against visual loss The current ophthalmic literature is varied with regard to GLP-1 receptor agonists and risk of NA-AION, and clinicians must stay informed as data continues to emerge on this topic References Mitchell JL, Lyons HS, Walker JK, et al

Never incinerate nor dispose the cells in fire